Could Casualty Medical Systems Incorporated (NASDAQ:CASM) Go Down After Its Newest Short Interest Report?

January 14, 2018 - By Darrin Black

 Could Casualty Medical Systems Incorporated (NASDAQ:CASM) Go Down After Its Newest Short Interest Report?

Investors sentiment decreased to 0.83 in 2017 Q3. Its down 0.37, from 1.2 in 2017Q2. It turned negative, as 2 investors sold CAS Medical Systems, Inc. shares while 4 reduced holdings. 2 funds opened positions while 3 raised stakes. 6.37 million shares or 4.99% more from 6.06 million shares in 2017Q2 were reported.
Royal Commercial Bank Of Canada has 0% invested in CAS Medical Systems, Inc. (NASDAQ:CASM). Vanguard Group Inc Inc, Pennsylvania-based fund reported 531,881 shares. Rmb Cap Mgmt Lc owns 20,000 shares for 0% of their portfolio. 5.09 million were accumulated by Acuta Prns Ltd Liability. Morgan Stanley reported 3,277 shares stake. Renaissance Technologies Ltd stated it has 281,800 shares or 0% of all its holdings. Northern owns 25,101 shares or 0% of their US portfolio. Blackrock holds 0% or 11,354 shares in its portfolio. Manatuck Hill Prtn Ltd Limited Liability Company reported 50,000 shares or 0.02% of all its holdings. 42,346 are owned by 1492 Mngmt Limited Liability. Wells Fargo Com Mn reported 227 shares or 0% of all its holdings. California Public Employees Retirement System has invested 0% in CAS Medical Systems, Inc. (NASDAQ:CASM). Td Mgmt Ltd Liability Com invested 0.01% in CAS Medical Systems, Inc. (NASDAQ:CASM). Guggenheim Cap Ltd holds 13,692 shares. Hightower Advsrs Limited Co invested in 245,489 shares.

The stock of Casualty Medical Systems Incorporated (NASDAQ:CASM) registered a decrease of 3.78% in short interest. CASM’s total short interest was 249,700 shares in January as published by FINRA. Its down 3.78% from 259,500 shares, reported previously. With 58,900 shares average volume, it will take short sellers 4 days to cover their CASM’s short positions. The short interest to Casualty Medical Systems Incorporated’s float is 1.27%.

The stock decreased 4.67% or $0.05 during the last trading session, reaching $1.02. About 31,319 shares traded. CAS Medical Systems, Inc. (NASDAQ:CASM) has declined 47.56% since January 14, 2017 and is downtrending. It has underperformed by 64.26% the S&P500.

CAS Medical Systems, Inc., a non-invasive cerebral oximetry technology company, develops, makes, and markets non-invasive patient monitoring products worldwide. The company has market cap of $27.88 million. The Company's FORE-SIGHT® Absolute Cerebral Oximeter provides non-invasive and continuous measurement of absolute cerebral tissue oxygenation in the brain for patients during critical care. It currently has negative earnings. The firm provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories.

More recent CAS Medical Systems, Inc. (NASDAQ:CASM) news were published by: Seekingalpha.com which released: “CAS Medical Systems’ (CASM) CEO Tom Patton on Q3 2017 Results – Earnings Call …” on November 12, 2017. Also Seekingalpha.com published the news titled: “CAS Medical Systems’ (CASM) CEO Tom Patton on Q1 2017 Results – Earnings Call …” on May 03, 2017. Globenewswire.com‘s news article titled: “CASMED Names Kimberly Strusky Executive Vice President of US Sales” with publication date: October 05, 2015 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: